Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Clinical presentation of stage IIIA (N2) non-small cell lung cancer - Roleof multimodality therapy
Autore:
Friedberg, JS;
Indirizzi:
Univ Penn, Med Ctr, Dept Surg, Philadelphia, PA 19104 USA Univ Penn Philadelphia PA USA 19104 Dept Surg, Philadelphia, PA 19104 USA
Titolo Testata:
CHEST
fascicolo: 6, volume: 116, anno: 1999, supplemento:, S
pagine: 497S - 499S
SICI:
0012-3692(199912)116:6<497S:CPOSI(>2.0.ZU;2-Q
Fonte:
ISI
Lingua:
ENG
Keywords:
multimodality therapy; neoadjuvant chemotherapy; non-small cell lung cancer; stage IIIA N2 disease; surgery;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
10
Recensione:
Indirizzi per estratti:
Indirizzo: Friedberg, JS Univ Penn, Med Ctr, Dept Surg, 3400 Spruce St, Philadelphia,PA 19104 USA Univ Penn 3400 Spruce St Philadelphia PA USA 19104 19104 USA
Citazione:
J.S. Friedberg, "Clinical presentation of stage IIIA (N2) non-small cell lung cancer - Roleof multimodality therapy", CHEST, 116(6), 1999, pp. 497S-499S

Abstract

Neoadjuvant chemotherapy before surgical resection of locally advanced non-small cell lung cancer (NSCLC) has been shown to improve survival comparedwith surgery alone in several randomized clinical trials. A case report ispresented describing the use of paclitaxel and carboplatin in a multimodality regimen for a patient with stage IIIA N2 NSCLC. Studies are ongoing to determine the optimal type and timing of chemotherapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/11/20 alle ore 00:01:59